Molecular research in cancer: future clinical applications.
作者信息
Ratliff T L
机构信息
Washington University School of Medicine, St. Louis, MO, USA.
出版信息
Acta Urol Belg. 1996 May;64(2):53-5.
PMID:8701813
Abstract
摘要
相似文献
1
Molecular research in cancer: future clinical applications.
Acta Urol Belg. 1996 May;64(2):53-5.
2
Gene therapy approaches in urologic oncology.
Surg Oncol Clin N Am. 1995 Apr;4(2):203-18.
3
The immunotherapy of prostate and bladder cancer.
BJU Int. 2005 Oct;96(5):728-35. doi: 10.1111/j.1464-410X.2005.05772.x.
4
Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
J Exp Pathol. 1987 Summer;3(4):587-92.
5
Molecular engineering of the antitumor immune response.
Bone Marrow Transplant. 1992;9 Suppl 1:182-6.
6
Ovarian tumour antigens as potential targets for immune gene therapy.
Gene Ther. 1995 Jan;2(1):7-15.
7
HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
Gene Ther. 2005 Dec;12(23):1686-95. doi: 10.1038/sj.gt.3302586.
8
Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
J Clin Invest. 1988 Dec;82(6):1811-7. doi: 10.1172/JCI113796.
9
Basic overview of current immunotherapy approaches in urologic malignancy.
Urol Oncol. 2006 Sep-Oct;24(5):413-8. doi: 10.1016/j.urolonc.2005.08.013.
10
Immunotherapy of prostate cancer.
Eur Urol. 2008 Apr;53(4):681-3; discussion 684-5. doi: 10.1016/j.eururo.2007.12.038. Epub 2008 Jan 3.
Zotero 插件